Optimizing Preclinical Models to Determine Gene Therapy Safety & Efficacy

Time: 2:45 pm
day: Day One: Track A PM

Details:

  • Preclinical development of AAV gene therapies for neurological disorders
  • Considerations for the development of AAV gene therapies
  • Preclinical development of AAV gene therapies

Speakers: